# A Study in Healthy Men to Test the Effects of Different Doses of BI 1467335 on MAO-B Activity in the Brain.

> **NCT03927209** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 1467335

## Key facts

- **NCT ID:** NCT03927209
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-06
- **Primary completion:** 2019-11-22
- **Final completion:** 2019-11-22
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03927209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03927209, "A Study in Healthy Men to Test the Effects of Different Doses of BI 1467335 on MAO-B Activity in the Brain.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03927209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*